Navigation Links
Sanofi-aventis Announces Second Quarter 2009 Results
Date:7/29/2009

Research and development expenses rose by 1.6% to euro 1,108 million. At constant exchange rates, they were down by 2.5%, reflecting selectivity in R&D projects and cost savings.

Selling and general expenses increased by 5.9%, or 1.5% at constant exchange rates, to euro 1,895 million. The ratio of selling and general expenses to net sales fell by 1.2 points to 25.5%, reflecting the ongoing program of adaptation to market conditions.

Other current operating income, net of expenses totaled euro 132 million, compared with euro 74 million for the second quarter of 2008. The year-on-year change in this line reflects gains on currency hedging and an increase in the royalty collected by sanofi-aventis on sales of Copaxone((R)) in North America.

Operating income - current was up 26.8% at euro 3,046 million. At constant exchange rates, growth was 16.0%. The ratio of operating income - current to net sales improved by 5.1 points to 41.0%.

Net financial expenses were virtually unchanged at euro 70 million. Financial expenses rose slightly, reflecting the change in net debt arising from payment of the Zentiva purchase consideration at the end of the first quarter and from the dividend payout.

The effective tax rate was 0.6 of a point lower at 29%, in line with the 2008 full-year rate.

The share of profits from associates was up 22.6% at euro 266 million, with the share of after-tax profits from territories managed by BMS under the Plavix((R)) and Avapro((R)) alliance 42.7% higher at euro 207 million due to a good performance by Plavix((R)) in the United States and a favorable dollar effect. The contribution from Merial rose by 21.6%, and the contribution from Sanofi Pasteur MSD also grew.

Minority interests were 5.7% higher at euro 111 million. The share of pre-tax profits paid to BM
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
4. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
5. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
6. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
7. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
8. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
9. Sanofi-aventis U.S. Announces Settlement of Medicaid Best Price Investigation
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... MA (PRWEB) December 23, 2014 ... webinar series is designed to introduce cutting ... inform users and partners of platform upgrades. ... and benefits; empowering users in their quest ... powerful tools. , According to SoundConnect’s Marketing ...
(Date:12/24/2014)... York (PRWEB) December 23, 2014 According to ... Long Island Affiliate of ITRA Global, the national office market ... steady recovery. This is evidenced by the third quarter’s ... stock market. Low energy costs have held inflation down ... only negative is the housing market remaining soft. , This ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 Nashville Fertility ... was elected treasurer for the American Society for Reproductive ... knowledge and research in reproductive medicine. In his ... seat on the executive board and will have a ... Dr. Hill has actively supported ASRM since 1984 when ...
(Date:12/24/2014)... CA (PRWEB) December 23, 2014 Pipette.com ... where their Twitter followers can submit their #HolidayInTheLab pictures ... and their lab mates. , For those struggling to ... mates, the Pipette.com Holiday in the Lab Contest provides ... Pipette.com Twitter followers to send pictures of their ...
Breaking Biology Technology:SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2
... William Heiser, Ph.D., Research ... Hercules, CA 94547, , ... We have found that the most ... distance and,microparticle size. Changing most other parameters, within a,broad range, ...
... A. Kimberley McAllister, Nina Tang, Lawrence C. Katz, and Donald ... Department of Neurobiology, Box 3209, Duke University Medical Center, , ... , Introduction ... cells and tissues of interest , remains a rate-limiting ...
... Katja Kapp, Werner Kunz, and Christoph G Grevelding,Institute for Genetics, Center of ... , Introduction ... parasitic helminths that cause bilharzia (schistosomiasis) , ... al.1997). , One focus of ...
Cached Biology Technology:Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 2Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 3Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 4Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 5Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 6Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 7Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 8Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 9Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 10Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 11Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 12Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 13Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 14Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 15Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 16Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 17Biolistic Transfection of Organotypic Brain Slices 2Biolistic Transfection of Organotypic Brain Slices 3Biolistic Transfection of Organotypic Brain Slices 4Biolistic Transfection of Organotypic Brain Slices 5Biolistic Transfection of Organotypic Brain Slices 6Biolistic Transfection of Organotypic Brain Slices 7Biolistic Transfection of Organotypic Brain Slices 8Biolistic Transfection of Organotypic Brain Slices 9Biolistic Transfection of Organotypic Brain Slices 10Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 2Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 3Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 4Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 5Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 6Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 7Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 8Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 9
(Date:12/19/2014)... , Dec. 18, 2014 Research and ... the addition of the "iPhone 5S Fingerprint ... Report" report to their offering. ... the acquisition of AuthenTec in July 2012, Apple ... 5S. It is currently the only device of ...
(Date:12/19/2014)...  23andMe, Inc., the leading personal genetics company, today ... differences in genetic ancestry of individuals from across ... immigrants first arrived more than four hundred years ago, ... as a meeting place for peoples from different continents. ... mixing of peoples with African, European, and American origins ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ... "Samsung Galaxy S5 - Home Button Synaptics Fingerprint ... http://photos.prnewswire.com/prnh/20130307/600769 ... than the iPhone 5S, Samsung introduces for the ... The Galaxy S5 home button presents ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... launched a collaborative project to develop and evaluate new ... AvecNet is a five year, 12 million project ... the European Union,s Seventh Framework programme. Because malaria ... to combating the disease. Wide scale use of ...
... and the United Kingdom have been awarded funding ... process of biological photosynthesis. The U.S. National Science ... Sciences Research Council (BBSRC) collaborated in issuing these ... to use sunlight and carbon dioxide to produce ...
... a resident in Medical Genetics in the Department of ... Medical Center, in Stanford Calif., was honored as the ... Foundation Clinical Genetics Fellowship in Biochemical Genetics at the ... Canada. The objective of the Genzyme/ACMG Foundation Award ...
Cached Biology News:€12 million ($16.9 million) project to develop new tools for malaria control 2NSF announces new awards that will investigate more efficient ways to harvest sunlight 2NSF announces new awards that will investigate more efficient ways to harvest sunlight 3NSF announces new awards that will investigate more efficient ways to harvest sunlight 4
Polyclonal Antibody to CLAN...
Goat polyclonal to MLH3 ( Abpromise for all tested applications). entrezGeneID: 27030 SwissProtID: Q9UHC1...
Rabbit polyclonal to NMDAR1 e/f/g/h ( Abpromise for all tested applications)....
Biotin anti-mouse Ly-49C/F/I/H...
Biology Products: